Bair Hugger Surgical Infection Lawsuit 2026 — MDL 2666 Dismissed, State Cases Active, and What Comes Next

The Bair Hugger litigation has had one of the more instructive trajectories in recent mass tort history. Thousands of plaintiffs, years of discovery, a federal MDL before a respected Minnesota court — and then, in 2022, a Daubert ruling that ended the MDL before a single bellwether trial reached a jury. For plaintiffs’ attorneys, it is a cautionary study in what happens when the science has not caught up to the litigation. For patients who may have been harmed, the picture is more complicated: the MDL is gone, but cases continue.

This post traces what the litigation established, where it stands as of May 2026, and what options remain for patients who developed severe joint infections after procedures using the device.

The Device, the Theory, and the Science

The Bair Hugger forced-air warming system works exactly as its name suggests: a unit heats air to a prescribed temperature, and that warm air is blown through channels in a perforated blanket or gown draped over the surgical patient. It is used to maintain core body temperature during surgery, preventing perioperative hypothermia — which is itself a risk factor for complications including increased infection susceptibility and cardiac events.

The device has been in clinical use since the 1980s and has FDA 510(k) clearance as a Class II medical device. By the time MDL 2666 was created, millions of procedures had involved the device.

The causation theory that animated the litigation was biomechanical: forced-air warming systems blow warm air underneath the sterile drape. Warm air rises. In an operating room equipped with laminar airflow — a system designed to push clean, filtered air downward over the surgical site, flushing contaminated air toward the floor — rising warm air could theoretically disrupt the airflow pattern, drawing bacteria-laden floor-level air toward the open surgical field.

The target in orthopedic surgeries was periprosthetic joint infection (PJI). When bacteria contaminate a joint replacement during the implantation procedure, the result can be a devastating infection that is extremely difficult to eradicate because bacteria form biofilms on the metal implant surface — biofilms that antibiotics cannot penetrate effectively without removing the hardware.

Plaintiffs argued that engineering and microbiological studies demonstrated this mechanism, and that clinical studies showed higher PJI rates in Bair Hugger-exposed surgical patients.

MDL 2666: How It Was Built and Why It Failed

MDL 2666 was created by the JPML and assigned to the U.S. District Court for the District of Minnesota — the same district where 3M is headquartered. The case was assigned to Judge Joan N. Ericksen.

Over several years, plaintiffs’ counsel and 3M conducted extensive discovery: internal 3M documents about the device’s design, clinical studies the company funded and sponsored, engineering analyses of airflow dynamics, and epidemiological data on PJI rates across institutions. The discovery phase produced substantial corporate document production that revealed internal concerns at 3M about the device’s potential airflow effects — documents that became central to plaintiffs’ failure-to-warn theory alongside the causation science.

The litigation reached its critical juncture at the Daubert hearing on general causation. In federal court, to survive summary judgment, plaintiffs must have expert testimony that meets the reliability requirements of Federal Rule of Evidence 702 as interpreted by Daubert v. Merrell Dow Pharmaceuticals. The standard, as interpreted by the Eighth Circuit, requires that:

1. The expert’s methodology is based on sufficient facts or data
2. The testimony is the product of reliable principles and methods
3. The expert has reliably applied the principles and methods to the facts of the case

Judge Ericksen found that the plaintiffs’ general causation experts — who were testifying that the Bair Hugger can cause PJI in orthopedic surgery patients — did not meet this standard. The core problems the court identified:

Methodological Issue	Court’s Finding
Reliance on observational studies	Susceptible to confounding variables; no randomized trial evidence
Particle count studies	Measured air particle levels but did not establish bacterial causation
Animal studies	Not reliably extrapolated to human surgical settings
Hill criteria application	Experts applied Bradford Hill criteria selectively and inconsistently
Publication bias	Positive studies more likely published; unpublished data favored 3M

The Eighth Circuit affirmed the exclusions and the resulting dismissals. The MDL formally closed.

What the Dismissal Did Not Resolve

Critically, the MDL dismissal was an evidentiary ruling, not a merits determination. The court did not find that the Bair Hugger is safe or that it cannot cause PJI. It found that the evidence offered by these specific plaintiffs, using these specific experts and methodologies, was not sufficiently reliable to submit to a jury under federal evidence rules.

This distinction matters for:

State court plaintiffs: States that use the Frye “general acceptance” standard rather than Daubert provide a different gateway for expert testimony. Under Frye, the question is whether the underlying methodology has gained general acceptance in the relevant scientific community — which does not necessarily require the same rigor as Daubert’s reliability inquiry. Several state court cases have proceeded and some have reached trial.

New federal plaintiffs with new evidence: Scientific research on forced-air warming and surgical site infections has continued. If new peer-reviewed studies or methodologies emerge that satisfy Daubert, plaintiffs could theoretically re-engage the federal courts, though the Eighth Circuit’s existing reasoning creates a high bar.

The Frye-jurisdiction state cases: Plaintiffs in California, Florida, New York, and other states that apply Frye or modified Frye standards may find courts more receptive to the scientific theories that federal courts rejected. As of May 2026, state court litigation continues actively.

The Regulatory Gap: FDA Clearance vs. Proven Safety

The Bair Hugger received FDA clearance through the 510(k) pathway, which requires showing substantial equivalence to a legally marketed predecessor device — not independent proof of safety and effectiveness through controlled trials. FDA clearance through 510(k) is neither an endorsement nor a finding that the device is safe for all uses.

This regulatory context is important in litigation because 3M uses FDA clearance as part of its defense. Plaintiffs respond that 510(k) clearance for a patient warming device says nothing about its potential to disrupt operating room airflow — that downstream effect was not part of the clearance review.

The FDA has not issued a safety communication specifically addressing the Bair Hugger and PJI risk, though it has received adverse event reports through its MAUDE (Manufacturer and User Facility Device Experience) database.

Worked Scenario 1 — The Total Knee Patient (Federal Filing)

A 68-year-old retiree in Minnesota undergoes total knee replacement surgery in 2019. The Bair Hugger is used intraoperatively. Six months post-surgery, she develops increasing knee pain, warmth, and elevated inflammatory markers. Joint aspiration confirms bacterial contamination — Staphylococcus aureus. She undergoes a two-stage revision: implant removal, antibiotic spacer placement, six weeks of IV vancomycin, then re-implantation. The second implant is ultimately removed due to persistent infection; she is left with a fusion of the knee joint.

Her attorney files in the District of Minnesota in 2021. The case is transferred to MDL 2666. Her case is dismissed with the MDL in 2022. She appeals, arguing that her specific expert — who relied on different studies than those excluded — was improperly swept into the general dismissal without individualized review. The Eighth Circuit examines whether the trial court properly applied case-specific analysis.

This scenario illustrates the appellate question that lingered after the MDL dismissal: did the broad dismissal treat each case as fungible when some plaintiffs may have stronger individual evidence?

Worked Scenario 2 — The State Court Case in California

A retired police officer in Los Angeles undergoes total hip replacement in 2021 using Bair Hugger warming. He develops deep PJI caused by MRSA. His two-stage revision fails; he ultimately requires amputation above the knee. His California attorney files in Los Angeles Superior Court in 2023. California applies the Kelly-Frye standard for new scientific evidence. The trial court in California holds a Kelly-Frye hearing and admits the plaintiffs’ expert testimony, finding the theory of forced-air warming disrupting laminar airflow has general acceptance in microbiological research, even if the specific clinical link to PJI rates is debated.

The case proceeds to discovery in California state court. 3M produces the same documents it produced in the federal MDL — including internal concerns about airflow disruption — and California plaintiffs have access to that record.

Worked Scenario 3 — The Limitations Question

A woman in Texas had total hip replacement surgery in 2018. She developed PJI in 2019, underwent revision surgery, and only learned about the Bair Hugger litigation in 2024 after reading about it online. Texas applies a two-year statute of limitations for products liability claims (Tex. Civ. Prac. & Rem. Code § 16.003). Her attorney argues that the discovery rule tolled the statute: she did not know and could not have reasonably known that the Bair Hugger — a routine piece of surgical equipment she was never told about — was potentially implicated in her infection. Texas courts apply the discovery rule narrowly in products cases. The attorney also researches whether the specific 2023 Eighth Circuit decision constitutes a “new” triggering event for knowledge — an argument with limited precedent but worth examining given the facts.

What Patients Should Do If They Believe They Were Harmed

If you underwent orthopedic implant surgery — particularly hip or knee replacement — and developed a periprosthetic joint infection, the questions to explore with an attorney include:

1. Was the Bair Hugger used? The operative report should identify warming device usage. Request your complete hospital and anesthesia records.
2. What bacteria caused your infection? Staphylococcus aureus and MRSA are the organisms most associated with the Bair Hugger theory; gram-negative infections have a different infection pathway.
3. What state was your surgery performed in? This determines whether Daubert or Frye governs, and the applicable limitations period.
4. When did you know or suspect the device’s role? This is the discovery rule start date for limitations analysis.

Given the MDL’s dismissal, realistic assessment of Bair Hugger cases in 2026 requires an attorney with specific knowledge of the post-MDL litigation landscape — both which state courts have been receptive and what expert methodologies have survived challenge since the Eighth Circuit ruling.

Connecting to the Broader Medical Device Landscape

The Bair Hugger litigation illustrates a pattern common across medical device mass torts: early plaintiffs’ verdicts or settlements, rising MDL filings, then a Daubert battle that can make or break the entire docket. The same dynamic played out with Bard PowerPort catheter cases and hernia mesh litigation — all involve implanted or intraoperative devices where proving that the specific device caused the specific injury requires expert testimony that must survive judicial gatekeeping.

For patients evaluating whether to file after MDL dismissal, the mass tort settlement payout timeline analysis is different — individual state court cases, not a global MDL fund, would govern recovery timing. And personal injury attorney fee arrangements on contingency mean an honest attorney will evaluate case viability carefully before accepting a Bair Hugger case in the post-MDL environment.

The Role of Hospital Procurement Decisions

One underexplored dimension of Bair Hugger litigation is the role of hospital procurement decisions. Most hospitals purchase surgical warming equipment through group purchasing organizations (GPOs) — consortium arrangements where hospitals get negotiated pricing on medical equipment. The 3M Bair Hugger had an entrenched position in hospital formularies based on decades of established use before the PJI theory emerged.

Individual plaintiff cases often benefit from a line of discovery focused on:

• When did the hospital learn about the laminar airflow disruption concern?
• Did 3M provide safety information to hospital purchasing departments or OR managers about the airflow theory?
• Did the hospital consider switching to conductive warming after the theory gained academic attention?
• Were surgeons and anesthesiologists at this hospital aware of the debate in the orthopedic literature?

Hospitals themselves are not defendants in the Bair Hugger product liability case — the claim runs against 3M as manufacturer. But hospital knowledge and conduct may become relevant to comparative fault analyses in jurisdictions where hospital negligence could be allocated.

Laminar Airflow Science: What the Engineering Evidence Actually Shows

The technical core of the Bair Hugger litigation is fluid dynamics — specifically, whether warm air currents from below the surgical drape can disrupt the engineered airflow of a laminar flow operating room.

Modern operating rooms designed for orthopedic implant surgery typically use a unidirectional (laminar) airflow system: HEPA-filtered air moves vertically downward over the surgical field at a measured velocity, continuously displacing and removing airborne particles — including skin-shedding bacteria — toward exhaust vents near the floor. The engineering principle is that a clean zone is maintained above the surgical site by constant downward displacement flow.

The Bair Hugger forces warm air upward from the warming blanket into the area below the drape. Warm air rises by convection. Plaintiffs’ engineers and fluid dynamics experts in MDL 2666 argued that this rising warm air creates convective plumes that can disrupt the downward laminar flow pattern, drawing floor-level air — which may contain skin bacteria shed from the patient’s body or from operating room personnel — upward toward the sterile field.

3M’s engineering experts countered that the air exchange rate in modern ORs is high enough to overcome any disruption; that modern Bair Hugger blankets are designed to direct air laterally rather than upward; and that computational fluid dynamics (CFD) modeling shows the temperature differential required to disrupt laminar flow is not achieved in actual OR conditions.

The fight over expert methodology — which CFD models are valid, whether particle count studies translate to bacterial contamination, whether findings from earlier-generation OR designs apply to modern facilities — is what destroyed the federal MDL. The underlying engineering debate has not resolved.

Financial Damages in Periprosthetic Joint Infection Cases

PJI after orthopedic implant surgery is among the most expensive complications in all of elective medicine. Understanding the damages available in a successful Bair Hugger case requires understanding the true cost of PJI:

Treatment Stage	Approximate Cost Range
Diagnostic workup (cultures, imaging, aspiration)	$5,000–$20,000
First-stage revision surgery (implant removal, spacer)	$50,000–$150,000
Inpatient IV antibiotic therapy (PICC line, 6 weeks)	$40,000–$80,000
Second-stage revision (new implant placement)	$50,000–$150,000
Outpatient antibiotic management and monitoring	$20,000–$50,000
Complications requiring additional procedures	Variable — potentially hundreds of thousands
Permanent joint fusion or amputation	Lifetime care cost in millions

These are economic damages — quantifiable medical costs. On top of that are non-economic damages: the pain of multiple surgeries, the months of disability and reduced mobility, the psychological impact of an outcome that was supposed to be a routine joint replacement.

For cases involving permanent disability or amputation, life care planners prepare detailed future cost analyses that capture ongoing medical needs, home modification costs, assistive device replacement, and future medical inflation. These expert analyses are essential for maximizing recovery in the most serious cases.

The Infection Type Matters for Causation

One of the most important facts in evaluating a Bair Hugger claim is the type of bacteria that caused the PJI. The Bair Hugger airflow theory specifically predicts that disrupted laminar flow would carry skin-commensal bacteria from the patient’s own skin or from operating room personnel toward the sterile implant site.

The organisms most associated with this contamination pathway:

• Staphylococcus aureus — including MRSA
• Coagulase-negative Staphylococci — including Staph. epidermidis
• Cutibacterium acnes — particularly in shoulder procedures

Gram-negative infections — caused by organisms like E. coli, Klebsiella, or Pseudomonas — do not fit the skin-contamination pathway and are more consistent with gut translocation, urinary source, or hematogenous spread from a separate infection. Cases involving gram-negative PJI face additional causation challenges because the mechanism connecting the Bair Hugger theory to gram-negative organisms is weaker.

Any Bair Hugger attorney should request the joint aspiration culture results and microbiology reports early in case evaluation. The organism species and its antibiogram are foundational to the causation analysis.

Where Things Stand

The scientific debate about forced-air warming and surgical site infections has not resolved simply because MDL 2666 was dismissed. Research continues. The clinical question — whether these devices disrupt laminar airflow in ways that matter for patient outcomes — remains an active area of investigation in anesthesiology and orthopedic surgery literature.

For patients harmed by PJI after orthopedic surgery, the MDL dismissal does not foreclose all legal options. It narrows them significantly in federal court, and it raises serious challenges in any jurisdiction. But state court cases continue, and the documents produced in MDL discovery are part of the public record available to future plaintiffs.

The pragmatic reality in 2026: Bair Hugger cases are harder to bring than they were before the MDL dismissal. An attorney who evaluates the case carefully — examining the organism type, the specific OR configuration, the patient’s risk factors, the applicable state evidence rules, and the limitations period — can still identify cases with viable paths forward. Cases with gram-positive PJI after hip or knee replacement in Frye-standard states, within limitations, remain candidates for serious evaluation.

Any patient considering a claim needs an attorney who can evaluate the current state of post-MDL scientific evidence and the specific procedural rules of the jurisdiction where surgery occurred.

---

This post is for informational purposes only and does not constitute legal advice. Consult a licensed attorney for advice specific to your situation and jurisdiction.